A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Three-quarters of camels in Saudi Arabia have evidence of the deadly virus behind Middle East Respiratory Syndrome, or MERS, finds a study by the Center for Infection and Immunity.
CUMC researchers have found direct evidence of a link between prenatal vitamin A deficiency and postnatal airway hyperresponsiveness, a hallmark of asthma.
Brief fever appears to be common in kids given influenza and pneumococcal vaccines together—new findings from Columbia and CDC researchers, published in JAMA Pediatrics.